|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
GE Healthcare GE Healthcare and Varian, Inc. Announce Pre-Clinical MRI System
GE Healthcare GE Healthcare and Varian, Inc. Announce Pre-Clinical MRI System
GE Healthcare and Varian, Inc. Announce Pre-Clinical MRI System
Wednesday, 13 May 2009 06:17 | 
| Company News - GE Healthcare |
GE Healthcare and Varian, Inc. announce a new pre-clinical 7T magnetic resonance imaging (MRI) system
GE Healthcare (NYSE: GE) and Varian, Inc. (NasdaqGS: VARI) announce the availability of the Discovery(TM) MR901, a new pre-clinical 7T magnetic resonance imaging (MRI) system which provides new capabilities for a broad range of research objectives.
The Discovery MR901 combines GE Healthcare's state-of-the-art diagnostic technology with Varian's leading scientific platform to provide a pre-clinical MRI system for the scientific community. The pre-clinical technology aims to excel in soft tissue contrast and non-invasive techniques, including those used in research for anatomy, metabolism, and physiology in research models.
"Our offering provides a new level of depth and versatility to the scientific community," said Jim Davis, Vice President and General Manager of Magnetic Resonance, GE Healthcare. "This introduction provides the opportunity to strengthen our footprint within clinical research while complementing our existing portfolio."
The range of preclinical MRI applications includes brain and organ imaging, tumor assessment, disease progression and functional imaging. Other potential research applications include investigation of new contrast mechanisms and agents, monitoring gene expression, analysis of protein interactions, and determination of pharmacokinetics.
Varian and GE Healthcare announced the Discovery MR901 at the International Society for Magnetic Resonance in Medicine (ISMRM) conference in Honolulu, Hawaii. The first unit is ready for shipment pending completion of the customer site.
"I am very pleased with how the system integration has progressed. The first system is expected to ship this summer, adding to our installed-base of leading MRI and NMR instrumentation," said David Rayner, Vice President of Research Products at Varian.
About Varian, Inc.:
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Further information is available on the company's Web site: http://www.varianinc.com.
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest. For more information about GE Healthcare, visit website at http://www.gehealthcare.com.
Source: GE Healthcare
The Discovery MR901 combines GE Healthcare's state-of-the-art diagnostic technology with Varian's leading scientific platform to provide a pre-clinical MRI system for the scientific community. The pre-clinical technology aims to excel in soft tissue contrast and non-invasive techniques, including those used in research for anatomy, metabolism, and physiology in research models.
"Our offering provides a new level of depth and versatility to the scientific community," said Jim Davis, Vice President and General Manager of Magnetic Resonance, GE Healthcare. "This introduction provides the opportunity to strengthen our footprint within clinical research while complementing our existing portfolio."
The range of preclinical MRI applications includes brain and organ imaging, tumor assessment, disease progression and functional imaging. Other potential research applications include investigation of new contrast mechanisms and agents, monitoring gene expression, analysis of protein interactions, and determination of pharmacokinetics.
Varian and GE Healthcare announced the Discovery MR901 at the International Society for Magnetic Resonance in Medicine (ISMRM) conference in Honolulu, Hawaii. The first unit is ready for shipment pending completion of the customer site.
"I am very pleased with how the system integration has progressed. The first system is expected to ship this summer, adding to our installed-base of leading MRI and NMR instrumentation," said David Rayner, Vice President of Research Products at Varian.
About Varian, Inc.:
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Further information is available on the company's Web site: http://www.varianinc.com.
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest. For more information about GE Healthcare, visit website at http://www.gehealthcare.com.
Source: GE Healthcare
